Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Hepatorenal Syndrome”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT01637454
What this trial is testing

TYPE 2 HEPATORENAL SYNDROME

Who this might be right for
Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS
Post Graduate Institute of Medical Education and Research, Chandigarh 46
Post-approval studies (Phase 4)UnknownNCT02489864
What this trial is testing

The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure

Who this might be right for
Hepatorenal Syndrome
Sun Yat-sen University 30
Early research (Phase 1)Ended earlyNCT01906307
What this trial is testing

LJPC-501 in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome Type I and Type II
La Jolla Pharmaceutical Company 6
Large-scale testing (Phase 3)Study completedNCT00240045
What this trial is testing

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Who this might be right for
Type 2 Hepatorenal SyndromeRefractory Ascites
University of Alberta 9
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation